Connect with us

Hi, what are you looking for?

Jewish Business News

Search results for "TEVA "

Business

–   Dan Propper, Chairman of the Israeli Osem Group of companies has sold the last of his shares to Swiss company Nestlé. The...

Business

– The network security company’s main patents are about to expire. – Check Point’s founder, chairman and CEO Gil Shwed – / By Shmulik Shelach...

Business

– Perrigo is acquiring Ireland’s Elan, a beneficiary of royalties from rival multiple sclerosis treatment, Tysabri. – – A safety warning by the US...

IPOs

– The medical devices company plans to raise the money at a company valuation of $500 million by February. – – Sources inform ”Globes”...

Blogs

–    ECONOMY & BUSINESS Record foreign currency reserves.  Israel’s foreign exchange reserves at the end of September 2013 stood at an all-time record...

Blogs

– In the 6th Oct 2013 edition of Israel’s good news, the highlights include: ·        Israeli scientists have made an important discovery in the fight against leukemia. ·        Ethiopian-born...

Blogs

–   Israel is a tiny country – a beacon of light in a vast region of darkness.  Inside the country, every Israeli seems...

StartUps

– Mooly Eden: Start-ups are fine, but we must attract the multinationals. – – “There is stigma over the tax breaks in the Law...

Business

– Credit Suisse sees Copaxone sales falling from $4 billion annually to $400, 000 in 2019 and predicts annual sales of over $1 billion...

Science

The Laquinimod-treated patients accumulated significantly less brain tissue damage caused by neurodegeneration, compared to placebo in MRI analyses.